149
Participants
Start Date
November 30, 2002
Study Completion Date
January 31, 2005
Vancomycin
1 gram IV every 12 hours for 7 to 14 days
Linezolid
600 mg every 12 hours (intravenously \[IV\] for a minimum of the first 4 days followed by a switch to oral if tolerated by patient) for a total duration of 7 to 14 days
Pfizer Investigational Site, The Bronx
Pfizer Investigational Site, Cortland Manor
Pfizer Investigational Site, Jamaica
Pfizer Investigational Site, Buffalo
Pfizer Investigational Site, Morgantown
Pfizer Investigational Site, Decatur
Pfizer Investigational Site, North East Atlanta
Pfizer Investigational Site, North East Atlanta
Pfizer Investigational Site, North East Atlanta
Pfizer Investigational Site, Augusta
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Louisville
Pfizer Investigational Site, Lexington
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Peoria
Pfizer Investigational Site, Peoria
Pfizer Investigational Site, Peoria
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Palm Springs
Pfizer Investigational Site, Rancho Mirage
Pfizer Investigational Site, Redlands
Pfizer Investigational Site, Sacramento
Pfizer Investigational Site, Sacramento
Pfizer Investigational Site, ‘Ewa Beach
Pfizer Investigational Site, Spokane
Pfizer Investigational Site, Spokane
Pfizer Investigational Site, Spokane
Pfizer Investigational Site, Norwalk
Pfizer Investigational Site, Waterbury
Pfizer Investigational Site, Waterbury
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Nashville
Pfizer Investigational Site, San Juan
Lead Sponsor
Pfizer
INDUSTRY